159 related articles for article (PubMed ID: 9324787)
41. [Dose-effect dependence after taking calcium antagonists in exertion stenocardia patients].
Shinbaeva NA; Vygodin VA; Martsevich SIu; Metelitsa VI
Ter Arkh; 1983; 55(3):122-7. PubMed ID: 6857524
[No Abstract] [Full Text] [Related]
42. Effect of ramipril on postrevascularization prevalence of angina and quality of life.
Kjøller-Hansen L; Steffensen R; Grande P
Int J Cardiol; 2004 Jun; 95(2-3):159-65. PubMed ID: 15193814
[TBL] [Abstract][Full Text] [Related]
43. [The possibility of the development of isosorbide dinitrate and nifedipine withdrawal syndromes in patients with stable stenocardia of effort].
Kutishenko NP; Martsevich SIu; Metelitsa VI
Ter Arkh; 1997; 69(9):47-51. PubMed ID: 9411826
[TBL] [Abstract][Full Text] [Related]
44. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
45. Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.
Yusuf S; Lonn E
Eur Heart J; 1998 Sep; 19 Suppl J():J36-44. PubMed ID: 9796839
[TBL] [Abstract][Full Text] [Related]
46. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
Baer JT; Sauer WH; Berlin JA; Kimmel SE
Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
[TBL] [Abstract][Full Text] [Related]
47. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
[TBL] [Abstract][Full Text] [Related]
48. [Stable ischemic coronary disease--medical therapy or PCI?].
Mickley H; Egstrup K
Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
[No Abstract] [Full Text] [Related]
49. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
50. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
[TBL] [Abstract][Full Text] [Related]
51. ["Running" pulse magnetic field in treating stenocardia].
Orlov LL; Makoeva LD; Pochechueva GA; Arzhanenko OM; Belinskaia TF
Biofizika; 1996; 41(4):949-52. PubMed ID: 8962896
[TBL] [Abstract][Full Text] [Related]
52. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
[TBL] [Abstract][Full Text] [Related]
53. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
[No Abstract] [Full Text] [Related]
54. [Relationship between myocardial ischemia and left ventricular dysfunction].
Z Kardiol; 1994 Oct; 83(10 Suppl):1-8. PubMed ID: 9131100
[No Abstract] [Full Text] [Related]
55. [The clinical picture of ischemic heart disease following a myocardial infarct].
Furkalo NK; Fursov VG
Lik Sprava; 1994; (5-6):109-11. PubMed ID: 7831871
[TBL] [Abstract][Full Text] [Related]
56. [Chrono-pharmacodynamics of capoten in patients with ischemic heart disease, postinfarction cardiosclerosis with cardiac failure].
Zaslavskaia RM; Zhamankulov KZh; Akhmetova AS; Teĭblium MM
Klin Med (Mosk); 2001; 79(12):33-5. PubMed ID: 11840808
[TBL] [Abstract][Full Text] [Related]
57. Heart failure: Part II.
Wilkes MS; Middlekauff H; Hoffman JR
West J Med; 1999 Jun; 170(6):339-42. PubMed ID: 10443162
[No Abstract] [Full Text] [Related]
58. [Newly occurring stenocardia: the clinical picture, diagnosis, treatment and prognosis].
Chernov SA; Nesterenko IuB; Abramov AN; Samosudova SIa
Voen Med Zh; 1993 Jun; (6):42-4, 80. PubMed ID: 8367951
[TBL] [Abstract][Full Text] [Related]
59. Management of chronic stable angina pectoris.
Rodríguez-Ospina L; Montano-Soto L
Bol Asoc Med P R; 2008; 100(4):39-47. PubMed ID: 19400528
[TBL] [Abstract][Full Text] [Related]
60. [The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease].
Shustval' NF
Lik Sprava; 1992 Sep; (9):73-6. PubMed ID: 1481512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
